Not all patients with CLL involve therapy. In spite of all the latest advancements, the iwCLL still endorses watchful observation for individuals with asymptomatic condition.86 This advice is based on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan https://camillak430jfx8.wikievia.com/user